Search

Wildfire and clearcutting are two main disturbances in North American forests, but whether root systems may respond differently to such disturbances is unknown. Here, we studied how the dynamics of fine roots (<2 mm in diameter) varied with stand origins in a boreal forest in northern Ontario, Canada. Fine root biomass increased with stand age, but did not differ between stands originating from fire and clearcutting. By contrast, fine root production, mortality and turnover rates were lower in 3- and 11-year-old clearcut-origin than fire-origin stands, but did not differ in 29-year-old stands of different stand origins. The lower rates of production, mortality, and turnover rates in 3- and 11-year-old clearcut-origin than fire-origin stands are attributable to a lower density of shrubs and herbs and larger nutrient pools after clearcutting than fire. The similarities among 29-year-old stands indicate that the effects of stand origin on fine root processes tend to converge at this time scale. Our results illustrate that time scale is critical for assessing ecosystem responses to disturbances. [ABSTRACT FROM AUTHOR]

Background: In the ROCKET AF (Rivaroxaban-Once-daily, oral, direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) trial, marked regional differences in control of warfarin anticoagulation, measured as the average individual patient time in the therapeutic range (iTTR) of the international normalized ratio (INR), were associated with longer inter-INR test intervals. The standard Rosendaal approach can produce biased low estimates of TTR after an appropriate dose change if the follow-up INR test interval is prolonged. We explored the effect of alternative calculations of TTR that more immediately account for dose changes on regional differences in mean iTTR in the ROCKET AF trial., Methods and Results: We used an INR imputation method that accounts for dose change. We compared group mean iTTR values between our dose change-based method with the standard Rosendaal method and determined that the differences between approaches depended on the balance of dose changes that produced in-range INRs ("corrections") versus INRs that were out of range in the opposite direction ("overshoots"). In ROCKET AF, the overall mean iTTR of 55.2% (Rosendaal) increased up to 3.1% by using the dose change-based approach, depending on assumptions. However, large inter-regional differences in anticoagulation control persisted., Conclusions: TTR, the standard measure of control of warfarin anticoagulation, depends on imputing daily INR values for the vast majority of follow-up days. Our TTR calculation method may better reflect the impact of warfarin dose changes than the Rosendaal approach. In the ROCKET AF trial, this dose change-based approach led to a modest increase in overall mean iTTR but did not materially affect the large inter-regional differences previously reported., Clinical Trial Registration: URL: ClinicalTrials.gov. Unique identifier: NCT00403767., (© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.)